Detalhe da pesquisa
1.
The effect of obesity pharmacotherapy on body composition, including muscle mass.
Int J Obes (Lond);
2024 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38745020
2.
Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
Cardiovasc Diabetol;
23(1): 174, 2024 May 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762719
3.
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
Diabetes Obes Metab;
2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38757729
4.
The economic burden of obesity in 4 south-eastern European countries associated with obesity-related co-morbidities.
BMC Health Serv Res;
24(1): 354, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38504302
5.
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study.
Diabetes Obes Metab;
25(9): 2561-2574, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37246799
6.
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity.
Pharmacol Res;
175: 105979, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34798266
7.
The beneficial short-term effects of a high-protein/low-carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes.
Diabetes Obes Metab;
23(8): 1765-1774, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33769666
8.
Motives for weight loss and weight loss maintenance: results from the MedWeight study.
J Hum Nutr Diet;
34(3): 504-510, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33493356
9.
Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
Am J Physiol Endocrinol Metab;
319(1): E105-E109, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32459524
10.
Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.
Diabetes Metab Res Rev;
36(5): e3297, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32026536
11.
Follistatins in glucose regulation in healthy and obese individuals.
Diabetes Obes Metab;
21(3): 683-690, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30393997
12.
The role of bariatric surgery to treat diabetes: current challenges and perspectives.
BMC Endocr Disord;
17(1): 50, 2017 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28797248
13.
The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus.
Eur J Nutr;
54(7): 1173-80, 2015 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25475658
14.
Multiple cranial nerve palsies in giant cell arteritis and response to cyclophosphamide: a case report and review of the literature.
Rheumatol Int;
35(4): 773-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25194431
15.
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
Metabolism;
151: 155741, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37995806
16.
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
Metabolism;
152: 155773, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38181882
17.
Effects of Wheat Biscuits Enriched with Plant Proteins Incorporated into an Energy-Restricted Dietary Plan on Postprandial Metabolic Responses of Women with Overweight/Obesity.
Nutrients;
16(8)2024 Apr 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38674919
18.
Relative Energy Deficiency in sport (REDs): Endocrine manifestations, pathophysiology and treatments.
Endocr Rev;
2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38488566
19.
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
Nat Med;
2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38740993
20.
Obesity Paradox: Fact or Fiction?
Curr Obes Rep;
12(2): 75-85, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36808566